These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20645402)

  • 1. Abnormal cardiac [(123)I]-meta-iodobenzylguanidine uptake in multiple system atrophy.
    Nagayama H; Ueda M; Yamazaki M; Nishiyama Y; Hamamoto M; Katayama Y
    Mov Disord; 2010 Aug; 25(11):1744-7. PubMed ID: 20645402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M; Hayashi M; Hirai S
    Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Yang T; Wang L; Li Y; Cheng M; Jiao J; Wang Q; Guo H
    J Neurol Sci; 2017 Feb; 373():48-51. PubMed ID: 28131225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.
    Chung EJ; Lee WY; Yoon WT; Kim BJ; Lee GH
    Mov Disord; 2009 Aug; 24(11):1650-5. PubMed ID: 19514077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy.
    Braune S; Reinhardt M; Schnitzer R; Riedel A; Lücking CH
    Neurology; 1999 Sep; 53(5):1020-5. PubMed ID: 10496261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiating Parkinson's disease from multiple system atrophy by [123I] meta-iodobenzylguanidine myocardial scintigraphy and olfactory test.
    Kikuchi A; Baba T; Hasegawa T; Sugeno N; Konno M; Takeda A
    Parkinsonism Relat Disord; 2011 Nov; 17(9):698-700. PubMed ID: 21840242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MIBG myocardial scintigraphy in progressive supranuclear palsy.
    Kamada T; Miura S; Kida H; Irie KI; Yamanishi Y; Hoshino T; Taniwaki T
    J Neurol Sci; 2019 Jan; 396():3-7. PubMed ID: 30391822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
    Saiki S; Hirose G; Sakai K; Kataoka S; Hori A; Saiki M; Kaito M; Higashi K; Taki S; Kakeshita K; Fujino S; Miaki M
    J Neurol Sci; 2004 May; 220(1-2):105-11. PubMed ID: 15140615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.
    Jacobson AF; Senior R; Cerqueira MD; Wong ND; Thomas GS; Lopez VA; Agostini D; Weiland F; Chandna H; Narula J;
    J Am Coll Cardiol; 2010 May; 55(20):2212-21. PubMed ID: 20188504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCOPA-AUT scale in different parkinsonisms and its correlation with (123) I-MIBG cardiac scintigraphy.
    Berganzo K; Tijero B; Somme JH; Llorens V; Sánchez-Manso JC; Low D; Iodice V; Vichayanrat E; Mathias CJ; Lezcano E; Zarranz JJ; Gómez-Esteban JC
    Parkinsonism Relat Disord; 2012 Jan; 18(1):45-8. PubMed ID: 21908227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion weighted imaging best discriminates PD from MSA-P: A comparison with tilt table testing and heart MIBG scintigraphy.
    Köllensperger M; Seppi K; Liener C; Boesch S; Heute D; Mair KJ; Mueller J; Sawires M; Scherfler C; Schocke MF; Donnemilier E; Virgolini I; Wenning GK; Poewe W
    Mov Disord; 2007 Sep; 22(12):1771-6. PubMed ID: 17579357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease.
    Courbon F; Brefel-Courbon C; Thalamas C; Alibelli MJ; Berry I; Montastruc JL; Rascol O; Senard JM
    Mov Disord; 2003 Aug; 18(8):890-7. PubMed ID: 12889078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole body and cardiac metaiodobenzylguanidine kinetics in Parkinson disease and multiple system atrophy: implications for the diagnostic role of imaging.
    Marini C; Bandettini di Poggio M; Pomposelli E; Marchese R; Nobili F; Morbelli SD; Villa G; Abbruzzese G; Sambuceti G
    Clin Nucl Med; 2010 May; 35(5):311-6. PubMed ID: 20395701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [123I-metaiodobenzylguanidine myocardial scintigraphy in the differential diagnosis of patients with parkinsonian syndromes -- case reports].
    Leńska-Mieciek M; Derecka-Charzyńska I; Fiszer U; Królicki L; Kułakowski P
    Neurol Neurochir Pol; 2005; 39(5):424-8. PubMed ID: 16273470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease.
    Orimo S; Ozawa E; Nakade S; Sugimoto T; Mizusawa H
    J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):189-94. PubMed ID: 10406987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular dysautonomia in Parkinson's disease and multiple system atrophy.
    Oka H; Mochio S; Yoshioka M; Morita M; Onouchi K; Inoue K
    Acta Neurol Scand; 2006 Apr; 113(4):221-7. PubMed ID: 16542160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between cardiac 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy.
    Lee PH; Yeo SH; Kim HJ; Youm HY
    Mov Disord; 2006 Nov; 21(11):1975-7. PubMed ID: 16960860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of relevance of
    Alves Do Rego C; Namer IJ; Marcel C; Lefebvre F; Lagha-Boukbiza O; Renaud M; Tranchant C; Anheim M
    J Neurol; 2018 Sep; 265(9):2033-2039. PubMed ID: 29956027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: a systematic review and a meta-analysis.
    Treglia G; Stefanelli A; Cason E; Cocciolillo F; Di Giuda D; Giordano A
    Clin Neurol Neurosurg; 2011 Dec; 113(10):823-9. PubMed ID: 21962800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metaiodobenzylguanidine (MIBG) scintigraphy at various parts of the body in Parkinson's disease and multiple system atrophy.
    Matsui H; Udaka F; Oda M; Kubori T; Nishinaka K; Kameyama M
    Auton Neurosci; 2005 Apr; 119(1):56-60. PubMed ID: 15893708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.